Metformin and Thyroid Disease: A Review
Overview of Metformin
An article in the Journal of Endocrinology examined the connection between the anti-diabetic medication metformin and thyroid disease. Metformin is the most commonly prescribed drug for type II diabetes, serving as the first-line treatment. It works primarily by reducing blood glucose levels through the inhibition of glucose production in the liver.
The Thyroid Gland and Its Functions
The thyroid gland, located in the neck, plays a crucial role in hormone secretion, including thyroxine (T4) and triiodothyronine (T3). These hormones are essential for regulating metabolism, development, cardiovascular health, sleep patterns, and cognitive functions. Thyroid stimulating hormone (TSH), produced by the pituitary gland, prompts the thyroid to produce T3 and T4. Any disruption in TSH or thyroid hormone production can lead to various thyroid disorders, which can significantly impact overall health.
Types of Thyroid Conditions
Thyroid disorders include:
– Hyperthyroidism: Increased thyroid activity
– Hypothyroidism: Decreased thyroid activity
– Goiter: Abnormally enlarged thyroid
– Thyroid nodules: Lumps of cells within the thyroid
– Thyroid cancer
Recent Findings on Metformin’s Impact on Thyroid Health
The recent review highlights that patients with elevated insulin levels typically exhibit larger thyroid volumes and a greater incidence of thyroid nodules and cancer. Remarkably, those taking metformin showed reduced thyroid volume and a lower likelihood of developing goiter, thyroid nodules, or cancer.
Supporting this, various laboratory studies indicate that metformin may inhibit the growth of thyroid nodules and cancers by interfering with specific signaling pathways. Furthermore, in diabetic patients diagnosed with thyroid cancer, metformin usage was linked to improved remission and survival rates. Additionally, metformin treatment consistently resulted in lower TSH levels, suggesting its potential as a complementary therapy for managing TSH suppression.
Conclusion and Future Directions
The authors of the review conclude that numerous studies conducted over the past decade provide compelling evidence for the potential use of metformin in treating thyroid conditions. Moreover, preliminary findings suggest that the benefits of metformin may extend to obesity and metabolic syndromes, warranting further investigation.
Written By: Katherine M. Evely, MS